Future studies including a higher number of patients with or without T2DM or HT, under the treatment with or without RAAS inhibitors and with or without DPP4i, which analyze both ACE and ACE2 levels on admission and in the follow-up, can more clearly demonstrate the association between ACE levels in COVID-19 infection. Here, ACE2 is linked to type 2 diabetes mellitus.